O'Shaughnessy Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.82M	Buy	142,308 +36,530	+35%	+$1.22M	0.02%	566
2026 Q1	$3.19M	Buy	105,778 +55,113	+109%	+$1.77M	0.02%	684
2025 Q4	$1.58M	Buy	50,665 +13,838	+38%	+$341K	0.01%	945
2025 Q3	$744K	Sell	36,827 -36,825	-50%	-$647K	﹤0.01%	1271
2025 Q2	$1.23M	Sell	73,652 -12,624	-15%	-$204K	0.01%	968
2025 Q1	$1.33M	Sell	86,276 -26,241	-23%	-$469K	0.01%	876
2024 Q4	$2.48M	Sell	112,517 -8,582	-7%	-$156K	0.02%	597
2024 Q3	$2.09M	Buy	121,099 +91,433	+308%	+$1.6M	0.02%	629
2024 Q2	$482K	Buy	29,666 +17,901	+152%	+$276K	0.01%	1149
2024 Q1	$166K	Buy	+11,765	New	+$148K	﹤0.01%	1532
2023 Q2	–	Sell	-10,700	Closed	-$94.7K	–	1575
2023 Q1	$94.7K	Buy	10,700 +487	+5%	+$4.82K	﹤0.01%	1294
2022 Q4	$93.1K	Buy	+10,213	New	+$89.1K	﹤0.01%	1208
2021 Q4	–	Sell	-1,286	Closed	-$13K	–	2362
2021 Q3	$13K	Buy	1,286 +145	+13%	+$1.36K	﹤0.01%	2090
2021 Q2	$11K	Sell	1,141 -87,029	-99%	-$921K	﹤0.01%	1982
2021 Q1	$1.02M	Buy	88,170 +87,634	+16,350%	+$1M	0.02%	398
2020 Q4	$5K	Hold	536	–	–	﹤0.01%	1688
2020 Q3	$5K	Sell	536 -91	-15%	-$963	﹤0.01%	1493
2020 Q2	$8K	Buy	+627	New	+$7.09K	﹤0.01%	1305
2016 Q3	–	Sell	-3,199	Closed	-$161K	–	967
2016 Q2	$161K	Sell	3,199 -217	-6%	-$11.6K	﹤0.01%	524
2016 Q1	$186K	Sell	3,416 -1,825	-35%	-$107K	﹤0.01%	460
2015 Q4	$344K	Sell	5,241 -5,851	-53%	-$362K	0.01%	400
2015 Q3	$641K	Buy	11,092 +5,632	+103%	+$365K	0.01%	350
2015 Q2	$323K	Sell	5,460 -4,131	-43%	-$255K	0.01%	434
2015 Q1	$598K	Buy	9,591 +6,869	+252%	+$399K	0.01%	356
2014 Q4	$157K	Buy	2,722 +305	+13%	+$17K	﹤0.01%	562
2014 Q3	$130K	Buy	2,417 +89	+4%	+$4.71K	﹤0.01%	587
2014 Q2	$122K	Buy	+2,328	New	+$119K	﹤0.01%	594

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

O'Shaughnessy Asset Management's TEVA Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 35% in Q2 2026, buying an estimated $1.22M and bringing the position to 142,308 shares worth $4.82M. The position accounts for 0.02% of the portfolio, ranked #566.

O'Shaughnessy Asset Management first reported a position in TEVA in Q2 2014 and has held it in 27 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

O'Shaughnessy Asset Management held 142,308 shares of Teva Pharmaceuticals worth $4.82M as of Q2 2026.
O'Shaughnessy Asset Management bought 36,530 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
Teva Pharmaceuticals made up 0.02% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #566 holding.
O'Shaughnessy Asset Management first reported a position in Teva Pharmaceuticals in Q2 2014 and has held it in 27 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.